These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7185773)

  • 1. Tranquillizer effects in an experimental analog of group psychotherapy.
    Krüger HP; Kohnen R
    Int Pharmacopsychiatry; 1982; 17(4):303-13. PubMed ID: 7185773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranquillizer effects in an experimental analog of verbal examinations.
    Kohnen R; Krüger HP
    Int Pharmacopsychiatry; 1982; 17(4):293-302. PubMed ID: 6136489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of performance of healthy volunteers given prazepam alone or combined with ethanol. Relation to drug plasma concentrations.
    Girre C; Hirschhorn M; Bertaux L; Palombo S; Fournier PE
    Int Clin Psychopharmacol; 1991; 6(4):227-38. PubMed ID: 1816280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of prazepam drops in the brief treatment of anxiety disorders].
    Ansseau M; Von Frenckell R
    Encephale; 1991; 17(4):291-4. PubMed ID: 1959497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-centre comparison of prazepam and diazepam in the treatment of anxiety.
    Dorman T
    Pharmatherapeutica; 1983; 3(6):433-40. PubMed ID: 6353434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Side-effects and changes of some physiological parameters after administration of a single 20 to 30 mg dose of prazepam. Double-blind study].
    Cazzato G; Zorzon M; Torre Antonello P; Carraro N; Monti F
    Clin Ter; 1983 Sep; 106(5):339-50. PubMed ID: 6641102
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of sublingual and oral prazepam in normal subjects. I. Clinical data.
    Ansseau M; von Frenckell R; Jacqmin P
    Neuropsychobiology; 1987; 18(2):77-82. PubMed ID: 3330182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prazepam in anxiety: a controlled clinical trial.
    Rickels K; Sablosky L; Silverman H; Case WG; Rial W; Mirman M; Gottlieb S
    Compr Psychiatry; 1977; 18(3):239-49. PubMed ID: 858240
    [No Abstract]   [Full Text] [Related]  

  • 9. Drowsiness sedation levels in anxious neurotic outpatients.
    Fabre LF; Johnson PA; Greenblatt DJ
    Psychopharmacol Bull; 1984; 20(1):128-36. PubMed ID: 6425914
    [No Abstract]   [Full Text] [Related]  

  • 10. Prazepam in the treatment of anxiety: a placebo-controlled multicenter evaluation.
    Weir JH
    J Clin Psychiatry; 1978 Dec; 39(12):841-7. PubMed ID: 721788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of prazepam with diazepam, chlorazepate dipotassium and placebo in anxious out-patients.
    Fabre LF; McLendon DM; Mallette A
    J Int Med Res; 1979; 7(2):147-51. PubMed ID: 39012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of prazepam on experimental hypertensive models].
    Ikuta J; Yamauchi Y; Shimizu S
    Nihon Yakurigaku Zasshi; 1982 Jun; 79(6):581-9. PubMed ID: 7129244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical symptomatology and computer analyzed EEG before, during and after anxiolytic therapy of alcohol withdrawal patients.
    Saletu M; Saletu B; Grünberger J; Mader R; Karobath M
    Neuropsychobiology; 1983; 9(2-3):119-34. PubMed ID: 6353268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind study of prazepam versus placebo in single daily doses in the treatment of anxiety.
    Goldberg HL; Finnerty RJ
    Compr Psychiatry; 1977; 18(2):147-55. PubMed ID: 319941
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prazepam drops versus 10 mg prazepam tablets in anxious patients in ambulatory care].
    Chabannes JP; Lemoine P
    Therapie; 1990; 45(6):467-70. PubMed ID: 2080484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo.
    Greenblatt DJ; Harmatz JS; Dorsey C; Shader RI
    Clin Pharmacol Ther; 1988 Sep; 44(3):326-34. PubMed ID: 3138056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients.
    Stella L; D'Ambra C; Mazzeo F; Capuano A; Del Franco F; Avolio A; Ambrosino F
    Life Sci; 2005 Oct; 77(21):2717-22. PubMed ID: 15979652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of benzodiazepine clinical activity: lack of direct relationship with plasma half-life. A comparison of single vs divided dosage schedules of prazepam.
    Ansseau M; Doumont A; von Frenckell R; Collard J
    Psychopharmacology (Berl); 1984; 84(3):293-8. PubMed ID: 6151206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeugenic factors in psychotherapy: the use of psychological tests.
    Bloom LJ; Trautt GM
    J Clin Psychol; 1978 Apr; 34(2):513-8. PubMed ID: 681534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC
    Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.